CardioVascular sells vascular unit to Escalon
This article was originally published in Clinica
CardioVascular Dynamics is to sell its Vascular Access business unit to Escalon Medical, for an undisclosed sum. Escalon will make an initial payment for the assets and operations of the business and will continue royalty payments for the next five years.
You may also be interested in...
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.